Posted by 
Retacrit is an erythropoiesis-stimulating agent ESA biosimilar to Epogen/Procrit (epoetin alfa) indicated for treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in patients with HIV infection. The drug is approved for use before and after surgery to reduce the chance that red blood cell transfusions will be needed because of blood loss during surgery.
Active ingredient in retacrit is epoetin alfa-epbx while inactive ingredients are calcium chloride dehydrate, glycine, isoleucine, leucine, L-glutamic acid, phenylalanine, polysorbate 20, sodium chloride, sodium phosphate dibasic anhydrous, sodium phosphate monobasic monohydrate, and threonine, in water for injection.
People with anemia have a lower-than normal number of RBCs. Retacrit works like the human protein-erythropoietin to help human body make more RBCs. Retacrit is used to reduce or avoid the need for RBC transfusions. It may be used to treat anemia if it is caused by chronic kidney disease and chemotherapy.
Common side effects of Retacrit include: joint, muscle, or bone pain, fever, cough, dizziness, high blood sugar, low potassium levels in the blood, chills, rash, nausea, vomiting, blood vessel blockage, low white blood cells, itching, headache, respiratory infection, weight loss and depression.
haleplushearty.org